Cargando…
Practical Use and Risk of Modafinil, a Novel Waking Drug
OBJECTIVES: Modafinil is a waking drug prescribed to narcolepsy patients, but its usage among healthy individuals is increasing to enhance their alertness or to mitigate fatigue. This study was conducted to investigate practical use and toxic effects on neuro-immune interaction of modafinil. METHODS...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Environmental Health and Toxicology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286657/ https://www.ncbi.nlm.nih.gov/pubmed/22375280 http://dx.doi.org/10.5620/eht.2012.27.e2012007 |
_version_ | 1782224575638011904 |
---|---|
author | Kim, Dongsoo |
author_facet | Kim, Dongsoo |
author_sort | Kim, Dongsoo |
collection | PubMed |
description | OBJECTIVES: Modafinil is a waking drug prescribed to narcolepsy patients, but its usage among healthy individuals is increasing to enhance their alertness or to mitigate fatigue. This study was conducted to investigate practical use and toxic effects on neuro-immune interaction of modafinil. METHODS: This study reviewed the significance of psychoactive drugs, and discussed the benefits and risks of the application of modafinil, which seems to be ideal as an anti-psychotic or anti-fatigue agent. RESULTS: Modafinil is known to have less or no adverse effects than those found in traditional psychostimulants such as amphetamine, methylphenidate or cocaine. It can be applied as an anti-psychotic or anti-fatigue agent. However, the waking mechanism of modafinil is yet to be fully revealed. Recent studies reported that modafinil may be subject to abuse and addiction. In addition prolonged sleeplessness induces stress responses and impairs immune function. CONCLUSIONS: Modafinil can be used by anyone, who wishes to work late, stay awake, enhance their cognitive reactions, or brighten their moods. Users may already be under a great level of stress, i.e. cancer patients or soldiers in a battle field. A psychoneuroimmunological approach is thus needed to investigate the multi-functional effects of modafinil. |
format | Online Article Text |
id | pubmed-3286657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Korean Society of Environmental Health and Toxicology |
record_format | MEDLINE/PubMed |
spelling | pubmed-32866572012-02-28 Practical Use and Risk of Modafinil, a Novel Waking Drug Kim, Dongsoo Environ Health Toxicol Brief Review OBJECTIVES: Modafinil is a waking drug prescribed to narcolepsy patients, but its usage among healthy individuals is increasing to enhance their alertness or to mitigate fatigue. This study was conducted to investigate practical use and toxic effects on neuro-immune interaction of modafinil. METHODS: This study reviewed the significance of psychoactive drugs, and discussed the benefits and risks of the application of modafinil, which seems to be ideal as an anti-psychotic or anti-fatigue agent. RESULTS: Modafinil is known to have less or no adverse effects than those found in traditional psychostimulants such as amphetamine, methylphenidate or cocaine. It can be applied as an anti-psychotic or anti-fatigue agent. However, the waking mechanism of modafinil is yet to be fully revealed. Recent studies reported that modafinil may be subject to abuse and addiction. In addition prolonged sleeplessness induces stress responses and impairs immune function. CONCLUSIONS: Modafinil can be used by anyone, who wishes to work late, stay awake, enhance their cognitive reactions, or brighten their moods. Users may already be under a great level of stress, i.e. cancer patients or soldiers in a battle field. A psychoneuroimmunological approach is thus needed to investigate the multi-functional effects of modafinil. The Korean Society of Environmental Health and Toxicology 2012-02-22 /pmc/articles/PMC3286657/ /pubmed/22375280 http://dx.doi.org/10.5620/eht.2012.27.e2012007 Text en © 2012 The Korean Society of Environmental Health and Toxicology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Review Kim, Dongsoo Practical Use and Risk of Modafinil, a Novel Waking Drug |
title | Practical Use and Risk of Modafinil, a Novel Waking Drug |
title_full | Practical Use and Risk of Modafinil, a Novel Waking Drug |
title_fullStr | Practical Use and Risk of Modafinil, a Novel Waking Drug |
title_full_unstemmed | Practical Use and Risk of Modafinil, a Novel Waking Drug |
title_short | Practical Use and Risk of Modafinil, a Novel Waking Drug |
title_sort | practical use and risk of modafinil, a novel waking drug |
topic | Brief Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286657/ https://www.ncbi.nlm.nih.gov/pubmed/22375280 http://dx.doi.org/10.5620/eht.2012.27.e2012007 |
work_keys_str_mv | AT kimdongsoo practicaluseandriskofmodafinilanovelwakingdrug |